Published in J Am Acad Dermatol on July 01, 1993
CB2 cannabinoid receptors as an emerging target for demyelinating diseases: from neuroimmune interactions to cell replacement strategies. Br J Pharmacol (2007) 0.91
Interleukin-12-induced adhesion molecule expression in murine liver. Am J Pathol (1998) 0.89
Selective induction of cell adhesion molecules by proinflammatory mediators in human cardiac microvascular endothelial cells in culture. Int J Clin Exp Med (2010) 0.84
The ontogeny of adhesion molecules expressed on the vascular endothelium of the developing human skin. J Anat (1996) 0.81
Novel expression of vascular cell adhesion molecule-1 (CD106) by squamous epithelium in experimental acute graft-versus-host disease. Am J Pathol (2002) 0.81
Lymphocytes, cytokines and adhesion molecules in chronic graft versus host disease. Clin Mol Pathol (1996) 0.75
Detection of a novel DNA virus (TTV) in blood donors and blood products. Lancet (1998) 5.15
Psoriasis in practice. Lancet (1991) 2.78
Identification of a major susceptibility locus on chromosome 6p and evidence for further disease loci revealed by a two stage genome-wide search in psoriasis. Hum Mol Genet (1997) 2.43
Cellular localization of interleukin-8 and its inducer, tumor necrosis factor-alpha in psoriasis. Am J Pathol (1991) 2.24
Predicting treatment response in psoriasis using serum levels of adalimumab and etanercept: a single-centre, cohort study. Br J Dermatol (2013) 2.10
Graft-versus-host disease after double-unit cord blood transplantation has unique features and an association with engrafting unit-to-recipient HLA match. Biol Blood Marrow Transplant (2013) 2.04
Expression of simple epithelial keratins 8 and 18 in epidermal neoplasia. J Invest Dermatol (1991) 1.87
Intestinal permeability in patients with eczema and food allergy. Lancet (1981) 1.69
A non-HLA gene within the MHC in psoriasis. Lancet (1999) 1.67
Creation of a double chimera after the transplantation of umbilical-cord blood from two partially matched unrelated donors. N Engl J Med (2001) 1.63
Methotrexate and liver fibrosis in people with psoriasis: a systematic review of observational studies. Br J Dermatol (2014) 1.57
Endothelial leucocyte adhesion molecule-1 (ELAM-1) expression in cutaneous inflammation. Br J Dermatol (1991) 1.57
A double blind, randomized, controlled clinical trial to assess the efficacy of a new coal tar preparation (Exorex) in the treatment of chronic, plaque type psoriasis. Clin Exp Dermatol (2000) 1.46
Psoriasis is associated with pleiotropic susceptibility loci identified in type II diabetes and Crohn disease. J Med Genet (2007) 1.44
Pulmonary capillary leak syndrome complicating generalized pustular psoriasis: possible role of cytokines. Br J Dermatol (1991) 1.41
Cutaneous endometriosis: a histopathologic study. J Am Acad Dermatol (1988) 1.37
Characterization of the major susceptibility region for psoriasis at chromosome 6p21.3. J Invest Dermatol (1999) 1.32
Cutaneous ectopic schistosomiasis. Br Med J (1976) 1.31
The role of adhesion molecules, chemotactic factors, and cytokines in inflammatory and neoplastic skin disease--1990 update. J Invest Dermatol (1990) 1.29
Identification of a novel psoriasis susceptibility locus at 1p and evidence of epistasis between PSORS1 and candidate loci. J Med Genet (2001) 1.23
The effect of in vivo interferon-gamma on the distribution of LFA-1 and ICAM-1 in normal human skin. J Invest Dermatol (1989) 1.22
Development of a novel flow cytometric cell-mediated cytotoxicity assay using the fluorophores PKH-26 and TO-PRO-3 iodide. J Immunol Methods (2001) 1.22
Intra-BM injection to enhance engraftment after myeloablative umbilical cord blood transplantation with two partially HLA-matched units. Bone Marrow Transplant (2009) 1.21
Inflammatory characteristics of platelet activating factor (PAF-acether) in human skin. Br J Dermatol (1984) 1.17
Complications of systemic corticosteroid therapy for problematic hemangioma. Plast Reconstr Surg (1999) 1.16
Genomic location and lack of phosphorylation of the HSV immediate-early polypeptide IE 12. J Gen Virol (1982) 1.14
Modulation of leucocyte adhesion molecules, a T-cell chemotaxin (IL-8) and a regulatory cytokine (TNF-alpha) in allergic contact dermatitis (rhus dermatitis). Br J Dermatol (1991) 1.14
Effects of long term treatment with tetracycline. Acta Derm Venereol (1974) 1.13
Accumulation of inflammatory cells in response to intracutaneous platelet activating factor (Paf-acether) in man. Br J Dermatol (1985) 1.13
Differential contribution of CDKAL1 variants to psoriasis, Crohn's disease and type II diabetes. Genes Immun (2009) 1.12
The development of excess numbers of melanocytic naevi in an immunosuppressed identical twin. Clin Exp Dermatol (1991) 1.12
Lichen aureus: a localized persistent form of pigmented purpuric dermatitis. Br J Dermatol (1985) 1.12
Premature rupture of membranes at 34 to 37 weeks' gestation: aggressive versus conservative management. Am J Obstet Gynecol (1998) 1.11
Neuropeptides induce rapid expression of endothelial cell adhesion molecules and elicit granulocytic infiltration in human skin. J Immunol (1993) 1.10
Thomas Addison, M.D. First dermatologist at Guy's Hospital. J Am Acad Dermatol (1982) 1.08
Localization of endothelial proliferation and microvascular expansion in active plaque psoriasis. Br J Dermatol (1997) 1.08
Juvenile elastoma and osteopoikilosis (the Buschke--Ollendorff syndrome). Br J Dermatol (1977) 1.07
Geographic and species association of hepatitis B virus genotypes in non-human primates. Virology (2003) 1.06
Surface-bound immunoglobulin E on antigen-presenting cells in cutaneous tissue of atopic dermatitis. J Invest Dermatol (1988) 1.05
Tumour necrosis factor alpha is pro-inflammatory in normal human skin and modulates cutaneous adhesion molecule expression. Br J Dermatol (1995) 1.02
A syndrome of various cutaneous pigmented lesions, myxoid neurofibromata and atrial myxoma: the NAME syndrome. Br J Dermatol (1980) 1.02
PUVA-induced repigmentation of vitiligo: a histochemical (split-DOPA) and ultrastructural study. Br J Dermatol (1979) 0.99
Effect of in vivo interleukin-1 on adhesion molecule expression in normal human skin. J Invest Dermatol (1992) 0.99
In situ quantification of T-lymphocyte subsets and Langerhans cells in the inflammatory infiltrate of atopic eczema. Br J Dermatol (1985) 0.99
Antibody-dependent cell-mediated cytotoxicity: a flow cytometry-based assay using fluorophores. J Immunol Methods (2001) 0.98
Effects of serum albumin, indomethacin and histamine H1-antagonists on Paf-acether-induced inflammatory responses in the skin of experimental animals and man. Br J Pharmacol (1985) 0.98
Nulliparous active labor, epidural analgesia, and cesarean delivery for dystocia. Am J Obstet Gynecol (1997) 0.97
Prevalence of lactase deficiency in British adults. Gut (1984) 0.97
Zoon's balanitis (balanitis circumscripta plasmacellularis). Br J Dermatol (1981) 0.97
Angioleiomyoma of the skin. Br J Dermatol (1974) 0.96
Molding therapy for infants with deformational auricular anomalies. Ann Plast Surg (1997) 0.96
The pathogenesis of amiodarone-induced pigmentation and photosensitivity. Br J Dermatol (1984) 0.95
Atypical pigmented lesions following extensive PUVA therapy. Clin Exp Dermatol (2000) 0.95
The simultaneous presence of Langerhans' cell and interdigitating cell antigenic markers on inflammatory dendritic cells. Clin Exp Immunol (1986) 0.94
Sequence diversity of TT virus in geographically dispersed human populations. J Gen Virol (1999) 0.94
Abnormal expression of epidermal growth factor receptor in cutaneous epithelial tumours. J Cutan Pathol (1992) 0.93
Importance of day 21 BM chimerism in sustained neutrophil engraftment following double-unit cord blood transplantation. Bone Marrow Transplant (2011) 0.93
Langerhans' cell expression of the selectin ligand, sialyl Lewis x. Immunology (1994) 0.92
Epidermal dendritic cells in psoriasis possess a phenotype associated with antigen presentation: in situ expression of beta 2-integrins. J Am Acad Dermatol (1992) 0.92
Sunlight exposure, antioxidant status, and cataract in Hong Kong fishermen. J Epidemiol Community Health (1993) 0.91
Contrasting effects of ultraviolet A1 and ultraviolet B exposure on the induction of tumour necrosis factor-alpha in human skin. Br J Dermatol (1998) 0.91
Absence of human leukocyte antigen molecules in skin tumors and some cutaneous appendages: evidence using monoclonal antibodies. J Am Acad Dermatol (1983) 0.91
Eruptive dysplastic naevi following renal transplantation. Clin Exp Dermatol (1988) 0.91
Human orf and milkers' nodule: a clinicopathologic study. J Am Acad Dermatol (1991) 0.91
Metastatic cutaneous carcinoid. J Am Acad Dermatol (1985) 0.90
Bone mineral density of patients with chronic plaque psoriasis. Clin Exp Dermatol (2001) 0.90
p53 immunoreactivity in human malignant melanoma and dysplastic naevi. Br J Dermatol (1993) 0.89
Calcifying arthropathy of the hips and diffuse hyperostosis associated with etretinate. Clin Exp Dermatol (1987) 0.89
Cutaneous periarteritis nodosa. Hepatitis B surface antigen-containing immunocomplexes and polymorphonuclear-leukocyte lysosomal enzyme release. Arch Dermatol (1984) 0.89
Posttransplant skin cancer: a possible role for p53 gene mutation but not for oncogenic human papillomaviruses. J Am Acad Dermatol (1994) 0.89
Caterpillar dermatitis. Clin Exp Dermatol (1983) 0.89
Cutaneous and pulmonary histopathological responses to platelet activating factor (Paf-acether) in the guinea-pig. J Pathol (1984) 0.89
Genetic analysis of PSORS2 markers in a UK dataset supports the association between RAPTOR SNPs and familial psoriasis. J Med Genet (2004) 0.88
Contrasting patterns of streptococcal superantigen-induced T-cell proliferation in guttate vs. chronic plaque psoriasis. Br J Dermatol (2001) 0.88
Loss of membrane B2 microglobulin in eccrine porocarcinoma. Its association with the histopathologic and clinical criteria of malignancy. Arch Dermatol (1984) 0.88
Fetal and neonatal cerebral blood flow. Am J Physiol (1966) 0.88
Affective symptoms and change in diabetes self-efficacy and glycaemic control. Diabet Med (2013) 0.88
Gamma-interferon induced human keratinocyte HLA-DR synthesis: the role of dermal activated T lymphocytes. Br J Dermatol (1988) 0.87
A randomized trial of epidural anesthesia to improve external cephalic version success. Am J Obstet Gynecol (1997) 0.87
Cutaneous lymphomatoid granulomatosis. Clin Exp Dermatol (1982) 0.87
Multiple naevoid basal cell carcinoma syndrome (Gorlin's syndrome). Clin Exp Dermatol (1979) 0.87
Profound digital collagen atrophy: a new cutaneous presentation of adrenal-dependent Cushing's syndrome. Br J Dermatol (1990) 0.87
A clinicopathological study of Flegel's disease (hyperkeratosis lenticularis perstans). Br J Dermatol (1987) 0.87
T-cell inducer populations in cutaneous inflammation: a predominance of T helper-inducer lymphocytes (THi) in the infiltrate of inflammatory dermatoses. Br J Dermatol (1990) 0.86
Alterations induced in normal human skin by in vivo interferon-gamma. Br J Dermatol (1990) 0.86
Cutaneous cryptococcosis. Br J Dermatol (1980) 0.86
Keratinocyte HLA-DR expression: the relationship to dermal lymphocytic infiltration. Clin Exp Dermatol (1987) 0.86
Age-independent and dose-response effects of ethanol on spatial memory in rats. Alcohol (2001) 0.86